Join the Probuphine group to help and get support from people like you.
Probuphine News
Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine
FRIDAY, Aug. 23, 2024 – Restricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of Drug ...
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder
FRIDAY, July 12, 2024 – Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28...
Most Americans Don't Know That Family Doctors Can Prescribe Anti-Opioid Meds
TUESDAY, July 2, 2024 – Most people addicted to opioids and their loved ones are unaware that their primary care doctor can prescribe a medication to treat the disorder, a new nationwide survey...
Only 1 in 4 People Who Need Meds to Fight Opioid Addiction Get Them
THURSDAY, June 27, 2024 – Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows. Boosting access to...
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds
WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...
Elimination of Buprenorphine Waiver Had Moderate Effect
MONDAY, May 6, 2024 – Elimination of the buprenorphine waiver increased the number of prescribers, but only modestly increased the number of patients in whom buprenorphine treatment was initiated,...
Monthly Injection Curbs Opioid Cravings, But Few Treatment Centers Use It
MONDAY, April 1, 2024 – A monthly long-acting injection of buprenorphine can be an easier and more effective therapy for people struggling with opioid addiction, but treatment centers aren’t much i...
It's Tougher for Non-White Americans to Get Opioid Addiction Drug, Buprenorphine
TUESDAY, Feb. 20, 2024 – Americans addicted to opioids who need the anti-addiction med buprenorphine are far more likely to find it if they live in a predominantly white neighborhood, new research...
Congenital Malformation Risk Lower With Buprenorphine Versus Methadone
THURSDAY, Jan. 25, 2024 – The risk for congenital malformations is lower in association with buprenorphine versus methadone for opioid use disorder in pregnancy, according to a study published...
One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD
WEDNESDAY, Nov. 8, 2023 – For individuals with opioid use disorder (OUD) using fentanyl, a one-day induction of extendedârelease buprenorphine is a feasible treatment approach, according to a study p...
Telemedicine Feasible for Buprenorphine Initiation in Opioid Use Disorder
MONDAY, Oct. 23, 2023 – Patients may benefit from the use of telemedicine during buprenorphine initiation for opioid use disorder (OUD) when compared with traditional initiation, according to a...
Higher Buprenorphine Dose Increases Likelihood of Staying in Treatment
THURSDAY, Sept. 21, 2023 – Patients initiating buprenorphine treatment for opioid use disorder who are prescribed a 24-mg dose are more likely to remain in treatment longer than those prescribed 16...
FDA Medwatch Alert: FDA Warns About Dental Problems with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder and Pain
What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the...
FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....
FDA Medwatch Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks
ISSUE: Based on additional review, FDA is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that...
Further information
Related condition support groups
Opiate Dependence - Maintenance, Opiate Dependence